Category: blog
-
Unlocking New Heights in Computational Drug Discovery: How Fovus Empowered a Series B Biotech Startup to Scale Faster by 96x and Reduce Costs by 5.5x
—
by
A stealth Series B biotech startup focused on developing innovative therapies faced significant challenges in managing its cloud-based high-performance computing (HPC) workflows. The company’s computational workloads included high-throughput virtual screening (HTVS), molecular docking, molecular dynamics simulations, and AI-augmented HTVS; each requiring immense computational power. However, managing cloud infrastructure, optimizing HPC strategies, and scaling clusters created…
-
Revolutionizing Protein Structure Prediction with AI and HPC: Utilizing AlphaFold
—
by
Predicting protein structures accurately has long been a significant challenge in biological research. Proteins, essential to nearly all biological processes, derive their functions from their three-dimensional structures. Understanding these structures enables drug discovery, genetic research, and biotechnology advancements. However, determining protein structures experimentally through methods like X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, or cryo-electron…
-
Transforming Computational Drug Discovery: Chemspace and Fovus
—
by
Chemspace Chemspace is a leader in the chemical compound marketplace and end-to-end computational chemistry services. Home to Enamine xREAL and Freedom Spaces – the world’s most extensive collection of commercially available chemical compounds with over 5 trillion molecules – Chemspace supports industries spanning biotechnology, life sciences, chemistry, and pharmaceuticals. By leveraging its vast database of…